Risks of metabolic syndrome in the ADVANCE and NAMSAL trials

INTRODUCTION: The ADVANCE and NAMSAL trials evaluating antiretroviral drugs have both reported substantial levels of clinical obesity in participants. As one of the main risk factors for metabolic syndrome, growing rates of obesity may drive metabolic syndrome development. This study aims to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tovar Sanchez, Tamara, Mpoudi-Etame, Mireille, Kouanfack, Charles, Delaporte, Eric, Calmy, Alexandra, Venter, Francois, Sokhela, Simiso, Bosch, Bronwyn, Akpomiemie, Godspower, Tembo, Angela, Pepperrell, Toby, Simmons, Bryony, Casas, Carmen Perez, McCann, Kaitlyn, Mirchandani, Manya, Hill, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Reproductive Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544962/
https://www.ncbi.nlm.nih.gov/pubmed/37791109
http://dx.doi.org/10.3389/frph.2023.1133556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544962/
https://www.ncbi.nlm.nih.gov/pubmed/37791109
http://dx.doi.org/10.3389/frph.2023.1133556

Ejemplares similares